Titan Pharmaceuticals Inc (TTNP)
7.09
+0.12
(+1.72%)
USD |
NASDAQ |
Apr 26, 16:00
7.09
0.00 (0.00%)
After-Hours: 20:00
Titan Pharmaceuticals Price to Book Value: 0.9760 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 25, 2024 | 0.9595 |
April 24, 2024 | 0.9595 |
April 23, 2024 | 0.965 |
April 22, 2024 | 0.965 |
April 19, 2024 | 1.008 |
April 18, 2024 | 0.9774 |
April 17, 2024 | 0.9774 |
April 16, 2024 | 0.999 |
April 15, 2024 | 0.999 |
April 12, 2024 | 0.9994 |
April 11, 2024 | 0.9856 |
April 10, 2024 | 1.010 |
April 09, 2024 | 1.010 |
April 08, 2024 | 0.9967 |
April 05, 2024 | 0.943 |
April 04, 2024 | 0.9485 |
April 03, 2024 | 0.9512 |
April 02, 2024 | 0.9884 |
April 01, 2024 | 0.9581 |
March 28, 2024 | 0.9856 |
March 27, 2024 | 1.016 |
March 26, 2024 | 0.9956 |
March 25, 2024 | 0.943 |
March 22, 2024 | 0.7647 |
March 21, 2024 | 0.8377 |
Date | Value |
---|---|
March 20, 2024 | 0.8304 |
March 19, 2024 | 0.8924 |
March 18, 2024 | 0.8912 |
March 15, 2024 | 1.054 |
March 14, 2024 | 0.8746 |
March 13, 2024 | 0.8383 |
March 12, 2024 | 0.9063 |
March 11, 2024 | 0.867 |
March 08, 2024 | 0.8099 |
March 07, 2024 | 0.8099 |
March 06, 2024 | 0.8099 |
March 05, 2024 | 0.8076 |
March 04, 2024 | 0.8678 |
March 01, 2024 | 0.8507 |
February 29, 2024 | 0.8507 |
February 28, 2024 | 0.8718 |
February 27, 2024 | 0.9574 |
February 26, 2024 | 0.9075 |
February 23, 2024 | 0.8825 |
February 22, 2024 | 0.8972 |
February 21, 2024 | 0.8618 |
February 20, 2024 | 0.9075 |
February 16, 2024 | 0.8077 |
February 15, 2024 | 0.7713 |
February 14, 2024 | 0.7713 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.478
Minimum
Dec 21 2023
23.81
Maximum
Mar 02 2020
5.182
Average
2.990
Median
Price to Book Value Benchmarks
Outset Medical Inc | 0.9885 |
Allurion Technologies Inc | -- |
AIM ImmunoTech Inc | 2.217 |
Protalix BioTherapeutics Inc | 2.503 |
Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
Price | 7.09 |
Earnings Yield | -104.5% |
Market Cap | 6.482M |